Ranbaxy

Long-term criminal fraud by Lipitor drugmakers exposed after years of selling adulterated drugs

Monday, July 01, 2013 by: J. D. Heyes
Tags: generic drugs, adulterated, Ranbaxy

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
BACK INTO THE CLOSET: Why U.S. reporters are not allowed to write about rainbow events in nations where being gay is still condemned
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
A family destroyed: Six-month-old dies after clinic injects baby with 13 vaccines at once without mother's informed consent
Biologist explains how marijuana causes tumor cells to commit suicide
U2's Bono partners with Monsanto to destroy African agriculture with GMOs
Companies begin planting microchips under employees' skin
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
ECONOMIC SLAVERY FOR ALL: While we were distracted with the Confederate flag flap, Congress quietly forfeited our entire economic future via fast-track trade authority
NJ cops bust teenagers shoveling snow without a permit
Russia throws down the gauntlet: energy supply to Europe cut off; petrodollar abandoned as currency war escalates
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
Chemotherapy kills cancer patients faster than no treatment at all
March Against Monsanto explodes globally... World citizens stage massive protests across 38 countries, 428 cities... mainstream media pretends it never happened
600 strains of an aerosolized thought control vaccine already tested on humans; deployed via air, food and water
Italian court rules mercury and aluminum in vaccines cause autism: US media continues total blackout of medical truth
The 21 curious questions we're never allowed to ask about vaccines
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Orthorexia Nervosa - New mental disorder aimed at people who insist on eating a clean diet

Delicious
(NaturalNews) The evidence continues to mount that Big Pharma is little more than a massive criminal enterprise designed to maximize profits at the expense of your health. This story is a continuation on that theme.

Thanks to investigative reporter Katherine Eban, we now know that one Indian drug manufacturer, Ranbaxy, has been making substantial profits selling bogus drugs, including generic brands of Lipitor (which is prescribed to lower cholesterol levels), and generally engaging in widespread fraud.

From her Special Report:

On May 13, Ranbaxy pleaded guilty to seven federal criminal counts of selling adulterated drugs with intent to defraud, failing to report that its drugs didn't meet specifications, and making intentionally false statements to the government. Ranbaxy agreed to pay $500 million in fines, forfeitures, and penalties - the most ever levied against a generic-drug company.

Massive fraud

The huge fines and shocking revelations stemmed from a months-long review of every single one of Ranbaxy's products, production lines and every market by Dinesh Thakur, who was ordered to undertake the project by his boss, Dr. Rajinder Kumar, Ranbaxy's head of research and development, in 2004.

What led Thakur - an American-trained engineer and a naturalized U.S. citizen who had worked at Bristol-Myers Squibb in New Jersey for a decade before joining Ranbaxy - to conduct his investigation was just the tip of the iceberg, but in the end it produced "some of the most devastating allegations ever made about the conduct of a drug company," Eban wrote. Here is an excerpt:

Back in his office, Kumar handed him a letter from the World Health Organization (WHO). It summarized the results of an inspection that WHO had done at Vimta Laboratories, an Indian company that Ranbaxy hired to administer clinical tests of its AIDS medicine. The inspection had focused on antiretroviral (ARV) drugs that Ranbaxy was selling to the South African government to save the lives of its AIDS-ravaged population.

As Thakur read, his jaw dropped. The WHO had uncovered what seemed to the two men to be astonishing fraud. The Vimta tests appeared to be fabricated. Test results from separate patients, which normally would have differed from one another, were identical, as if Xeroxed.


In the end, Thakur's "information would lead Ranbaxy into a multi-year regulatory battle with the FDA, and into the crosshairs of a Justice Department investigation that, almost nine years later, has finally come to a resolution," said Eban.

In 2007 Thakur filed a confidential whistleblower complaint in federal court, alleging that the company falsified and fabricated its data in order to win Food and Drug Administration approvals. Under the whistleblower law, he will receive more than $48 million as part of the case's resolution.

What would make a Big Pharma giant become so careless (and callous) in the production of its products? The answer: Money - and lots of it.

'The whole house of cards will fall'

Eban notes that the global generic medicine market alone is worth $242 billion annually. What's worse for Americans, more "than 80 percent of active pharmaceutical ingredients for all U.S. drugs now come from overseas, as do 40 percent of finished pills and capsules," she says.

In the U.S., doctors and patients are trending heavily towards generic medications as a means of controlling costs. But, as the Ranbaxy case proves, this choice presents special hazards of its own.

Notes Eban:

As the Ranbaxy story makes vividly clear, generic-drug makers intent on breaking the rules - especially those operating abroad - can easily do so. Drug applications work on the honor system: The FDA relies on data provided by the companies themselves.

"We depend on that information to be truthful," Gary Buehler, head of the FDA's office of generic drugs for 10 years, said in December 2009.

The approval system "requires the ethical behavior of the applicant," he said. Otherwise, "the whole house of cards will fall down."

Sources for this article include:

http://www.healthcarepackaging.com

http://features.blogs.fortune.cnn.com

http://www.naturalnews.com/Big_Pharma.html

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.